Objective To describe a series of patients with pathogenic variants in FLNA and progressive lung disease necessitating lung transplantation.
H eterozygous loss-of-function pathogenic variants in FLNA, the gene encoding filamin A, have been associated with X-linked periventricular nodular heterotopia (PVNH; MIM:300049), which is characterized by masses of heterotopic gray matter adjacent to the walls of the lateral ventricles. 1 In contrast, gain-of-function pathogenic variants in the same gene are associated with Melnick-Needles syndrome (MIM:309350), otopalatodigital syndrome type 1 (MIM:311300), otopalatodigital syndrome type 2 (MIM:304120), and frontometaphyseal dysplasia (MIM:305620).
2 X-linked PVNH typically affects females and is associated with epilepsy and normal to near normal cognition, whereas hemizygous males often do not survive. 1 Additional phenotypes that have been observed in a subset of patients with X-linked PVNH and FLNA pathogenic variants include Ehlers-Danlos syndrome-like features, [3] [4] [5] [6] cardiovascular anomalies, 4, 5, [7] [8] [9] and intestinal pseudo-obstruction. 4, 10, 11 Moreover, pulmonary complications of varying severity have been associated with this disorder, [3] [4] [5] [12] [13] [14] [15] [16] and a few patients with progressive obstructive pulmonary disease in early childhood leading to respiratory failure have been reported. 12, 13, [17] [18] [19] We describe a cohort of patients with heterozygous pathogenic variants in FLNA and progressive lung disease leading to respiratory failure in infancy and discuss the use of lung transplantation to promote survival in patients with severe pulmonary complications in this disorder. Some of the results of these studies have been reported previously in the form of abstracts and a case report. 14, 16, 20, 21 
Methods
We conducted a retrospective review of the medical charts of all patients in the pulmonary clinic at Texas Children's Hospital with both pathogenic variants in FLNA and lung disorders diagnosed between 2005 and 2015. Data on clinical presentation, physical examinations, genetic testing, imaging study findings, bronchoscopy findings, intraoperative observations, pathology findings, management, and outcomes were compiled and compared. All genetic testing was performed during the course of routine clinical care through commercial genetic testing laboratories. For cases [1] [2] [3] [4] [5] was performed at Children's Hospital Boston's Genetic Diagnostic Laboratory (Boston, Massachusetts), and for case 6, Sanger sequencing of FLNA was performed at Ambry Genetics (Aliso Viejo, California). This study was approved by Baylor College of Medicine's Institutional Review Board. At age 4 months, a full-term female developed acute respiratory failure after a febrile illness. Her physical examination was significant for respiratory distress, ligamentous laxity, and strabismus. Echocardiography revealed a large patent ductus arteriosus (PDA), a patent foramen ovale (PFO), and pulmonary hypertension. The PDA was ligated. Because of increasing tachypnea and intermittent hypoxemia at age 7 months, lung ventilation-perfusion scintigraphy was ordered and revealed diffuse irregular matched defects of ventilation and perfusion, largest in the right upper lobe. Serial chest radiographs (Figure 1) showed multifocal atelectasis and pulmonary hyperinflation that worsened over time. Chest computed tomography (CT) (Figure 1) showed severe pulmonary hyperinflation and hyperlucency with peripheral pulmonary vascular attenuation and air-trapping, parahilar and dependent lower lobe atelectasis, central pulmonary artery enlargement, and tracheobronchomalacia. Chronic respiratory failure ensued, leading to the need for mechanical ventilation and tracheostomy at age 13 months. She was listed for lung transplantation at age 14 months, and bilateral lung transplantation was performed at age 15 months. Intraoperatively, the lungs were severely hyperinflated. Histopathology revealed a generalized lung growth abnormality with alveolar enlargement and simplification and pulmonary hypertensive arteriopathy (Figure 2 ; available at www.jpeds.com). At age 21 months, head magnetic resonance imaging (MRI) showed PVNH, a thinned corpus callosum, and a posterior fossa arachnoid cyst (Figure 3; available at www.jpeds.com). DNA testing identified a de novo heterozygous pathogenic variant in FLNA that results in a frameshift (c.4596het_dupG). She also developed progressive severe dilatation of the ascending aorta with mild dilation of the aortic root and mild aortic regurgitation. The patient, now 12 years old, has shown improved gross motor development with normal cognition, but has attention deficit hyperactivity disorder. Her cardiopulmonary status is stable despite airflow limitation with a forced expiratory volume in 1 second of 52% predicted and radiographic and physiological evidence of bronchiolitis obliterans syndrome.
Results

Pulmonary Findings
Since the index case presented, we have cared for 5 additional females with heterozygous pathogenic variants in FLNA and progressive lung disease necessitating bilateral lung transplantation ( Table I) . Five of the 6 patients had initial respiratory distress during the neonatal period, but all improved. Chronic respiratory failure developed at a median age of 9 months (range, 7 weeks to 11 months), and the duration of mechanical ventilation ranged from 2 weeks to 6 months before transplantation. Ventilatory requirements were high, with median peak inspiratory pressure of 31 cm H2O and positive end-expiratory pressure of 10 cm H2O. The fraction of inspired oxygen ranged from 0.35 to 0.90. All patients were heavily sedated owing to challenging ventilator management, and 4 patients required regular dosing of neuromuscular blockade. Each patient required elective tracheostomy between 3 and 13 months of age. All patients demonstrated progressive pulmonary hyperinflation accompanied by scattered atelectasis on serial chest radiographs (Figure 1) . On chest CT, all exhibited severe pulmonary hyperinflation and hyperlucency with peripheral pulmonary vascular attenuation with parahilar and dependent lower lobe atelectasis and central pulmonary artery enlargement (Figure 1) . Air-trapping and airway malacia were noted in both patients in whom chest CT scans included inspiratory/expiratory series. Airway malacia was observed on bronchoscopy in 5 patients (Figure 2 ).
Pulmonary Artery Hypertension
All patients were diagnosed with pulmonary arterial hypertension via echocardiography in infancy. Sildenafil was prescribed for each infant, and prostacyclin therapy was added in 1 patient just days before transplantation. Although all patients had preoperative right ventricular dilation, none developed right ventricular dysfunction.
Cardiovascular Findings
Each patient had a PDA and a PFO (Table II; available at www.jpeds.com). All patients had mild to severe dilation of the ascending aorta early in life, with universal progression to severe dilation (Figures 4 and 5 ; available at www.jpeds.com). Given that the main area of dilation was >1.5 cm distal to the sinotubular junction, an area not routinely imaged on echocardiography and not well visualized on noncontrast chest CT, the dilation was first noted on contrast-enhanced chest CT or magnetic resonance angiography (MRA). One patient had supraventricular tachycardia and frequent premature ventricular contractions.
Given the previous description of tortuosity in a patient with a pathogenic variant in FLNA, vertebral artery tortuosity as a measure of arterial tortuosity was assessed in 3 of 6 patients who were undergoing CT angiography. 7, [22] [23] [24] The vertebral artery tortuosity index (VTI) is a reproducible measure derived from 3D MRA or CT angiography, with a higher VTI associated with adverse cardiovascular outcomes in connective tissue disorders. 22 Two patients showed mildly increased tortuosity with a VTI of 14 (normal, 4.0 ± 2.5) (Table II; Figure 6 , available at www.jpeds.com).
Neurologic Findings
Brain imaging demonstrated PVNH in all 6 patients, thinning or dysgenesis of the corpus callosum in 4 patients, and an enlarged cisterna magna or retrocerebelllar arachnoid cyst in 5 patients (Table II) . At the time of this report, no patient in our cohort had developed seizures. One patient has exhibited persistent developmental delays in the setting of additional head MRI findings of cortical atrophy and gliosis presumed to be secondary to chronic hypoxia before transplantation.
Lung Transplantation
Patients were listed for lung transplantation at age 5-14 months. Bilateral lung transplantation was performed at age 5-15 months with a median wait time of 35 days (range, 18-104 days). At transplantation, the explanted lungs were severely hyperinflated and emphysematous. In 5 patients, the tracheostomy was decannulated within 4 months of transplantation. All survivors were on ambient air, 1 each at 19 months, 3 years, 4 years, 5.1 years, and 11.3 years of post-transplantation follow-up. One patient has a complex tracheal stenosis and malacia with chronic compensated symptoms leading to delayed decannulation. One patient developed progressive respiratory insufficiency, preventing tracheostomy decannulation after an early bout of adenovirus pneumonia. Because of the ensuing development of bronchiolitis obliterans and development of moderate aortic valve regurgitation and severe dilation of the ascending aorta, she underwent heart-lung transplantation at age 3 years, but died of viral pneumonia at 8 weeks after surgery.
Otherwise, the post-transplantation course of the surviving 5 patients was similar to that of patients without pathogenic variants in FLNA except for the cardiac manifestations outlined above, which necessitated close monitoring. Of note, although mild tracheomalacia was noted in all patients after transplantation, in only 1 patient was it of clinical significance, causing a delay in decannulation.
Pulmonary Histopathology
Histopathology analysis of lung biopsy and explant specimens revealed severe alveolar enlargement and simplification, scattered pulmonary hemorrhages, and widespread hemosiderin-laden macrophages (Table III ; available at www.jpeds.com). A variable degree of hypertensive pulmonary arteriopathy was seen in all patients, with muscularization of lymphatics and veins observed in most patients. Airway cartilage was judged deficient in 4 patients. Elastic fibers in the lungs were abnormal, with loss of elastin peripherally and 
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Molecular Findings
In the first 2 patients, a presumed diagnosis of FLNA-associated PVNH was based on findings from head MRI, and commercially available FLNA testing was not available until years later. In the remaining patients, presumptive diagnosis followed by confirmatory genetic testing was made at an increasingly early stage of pulmonary disease. Four patients had frameshift pathogenic variants, and 1 patient had a missense variant that was reported previously (Table IV ; available at www.jpeds.com).
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The sixth patient has a missense variant of unknown significance at a lysine residue that is conserved in most vertebrate organisms except zebrafish, chicken, and lamprey. Although prediction software (Polyphen-2, SIFT) predicts that this amino acid change may be benign or tolerated, this variant is novel and not present in the ExAC database (http://exac.broadinstitute .org/), which supports pathogenicity. 26, 27 Pathogenic variants were de novo in all 4 patients in whom parental testing could be performed (cases 1, 2, 3, and 5).
Discussion
Our series of 6 patients demonstrates that heterozygous presumed loss of function pathogenic variants in FLNA can be associated with a lung disorder characterized by simplified enlarged alveolar air spaces and hyperinflation simulating emphysema, implying an important role of filamin A in alveolar modeling during lung growth. Our patients had a similar clinical course with respiratory disease as their presenting feature and similar associated clinical findings. In our patients, this unique lung growth disorder led to unrelenting respiratory failure during infancy. Although the pathogenic variant in FLNA was diagnosed at an earlier stage in recent cases, the lung disease was nonetheless progressive and relentless. Early clinical recognition on the basis of imaging and/or histopathology findings is important to guide genetic testing and counseling, and referral for consideration for lung transplantation.
We described this novel association of pathogenic variants in FLNA and PVNH with a characteristic lung growth disorder resembling severe emphysema on imaging and pathology in our first 2 cases. 14, 16 Additional cases of lung disease associated with pathogenic variants in FLNA have been subsequently reported (Table V; available at www.jpeds.com). 3, 4, 7, 12, 13, [17] [18] [19] [28] [29] [30] The association of pulmonary pathology with pathogenic variants in FLNA is further supported by a mouse model. 31 Approximately 20% of female mice heterozygous for the FLNA null allele died within the first 3-4 months of life, with evidence of lung edema and emphysema on necropsy. 31 Because the lungs are subjected to markedly varying spatiotemporal mechanical forces during respiration, and because filamin A is necessary for the mechanosensing and mechanotransducing behavior of cells, 32 abnormal filamin A interactions could alter lung viscoelasticity and disturb alveolar modeling, although the exact mechanisms for this are unclear.
We propose that the lung disease in our case series and in previously published reports has features of "lung growth disorders." 33 These lung growth disorders are characterized by defective alveolarization with lobular simplification, deficient alveolar septation, and airspace enlargement that may be misinterpreted as "emphysematous" changes. Chest CT findings of lung growth disorders exhibited by all 6 patients include distortion of the lung architecture with hyperlucency related to alveolar enlargement and reduced distal vascularization. 14 However, our patients had several imaging findings not previously associated with lung growth disorders, including progressively severe pulmonary hyperinflation and ascending aorta dilation in all 6 patients and airway malacia in 5 patients, which likely represent manifestations of altered viscoelastic properties of the affected tissues. The histopathological evidence of abnormal elastin suggests that loss of elastic recoil plays a role in the development of chronic respiratory failure. The pulmonary hyperinflation in our patients worsened after sustained positive-pressure ventilation, whereas at least 1 other reported case of lung disease associated with a pathogenic variant in FLNA and no ventilator requirement improved over time, suggesting exacerbation of the abnormalities in lung viscoelasticity and alveolar modeling by barotrauma. 12, 34 These abnormalities likely contribute to the chronic irreversible airflow limitation, owing to a loss of elastic recoil and an increase in airflow resistance through the complex conducting system of the lungs.
In our cases, chest CT revealed central pulmonary artery enlargement and echocardiography demonstrated right ventricular hypertrophy with an elevated tricuspid regurgitant jet and flattened interventricular septum. All 6 patients were treated empirically for pulmonary arterial hypertension with enteral sildenafil. Pulmonary hypertension did not regress in the 3 patients who underwent surgical PDA ligation before lung transplantation, and histopathology demonstrated arteriopathy in each case (Figure 2) . Factors contributing to the pulmonary arterial hypertension likely include alveolar hypoxia, diminished alveolar septal vasculature and blood flow, and progressive disruption of lung tissue integrity via pulmonary barotrauma. Right heart changes resolved after lung transplantation in each case. The ascending aorta dilation progressed after transplantation, however.
All of our patients had cardiovascular manifestations, including PDA, PFO, and ascending aortic dilation. Two patients had mild arterial tortuosity, and 1 patient had arrhythmia. Pathogenic variants in FLNA have been described in association with a broad spectrum of cardiovascular disorders, often in conjunction with joint laxity and other signs of connective tissue disorders. These cardiovascular disorders include PDA; atrial septal defect; ventricular septal defect; mitral valve prolapse; diffuse valve dysplasia; aortic regurgitation; dilation of the aortic root (sinus of Valsalva), ascending aorta, abdominal aorta, and other arteries; coarctation of the aorta; arterial stenosis; and arterial tortuosity. 4, 7, 9, 23, 28, 35 A single case report described complex congenital heart disease (mitral atresia, double-outlet right ventricle, coarctation of the aorta) in an infant with a FLNA pathogenic variant. 28 FLNA pathoJuly 2017
ORIGINAL ARTICLES genic variants also have been noted in patients with rhythm disorders and sudden death. 36 The mechanism of cardiovascular disease has not been elucidated. It has been postulated that pathogenic variants in FLNA lead to impaired binding ability of filamin A, which may impair cellular actin cytoskeleton remodeling in response to mechanical stress and cytokine stimulation. 37 Another hypothesis is that aberrations in filamin A alter transforming growth factor b signaling through its interactions with Smad proteins. 38 The most concerning of the cardiovascular features is the progressive aortic dilation. In other genetically mediated disorders with similar features, such as Marfan syndrome, LoeysDietz syndrome, and familial thoracic aneurysm and dissection disorders, aortic dilation is a precursor of aortic dissection and rupture, which is associated with high mortality. To our knowledge, to date, aortic dissection has not been reported in a patient with a confirmed pathogenic variant in FLNA, although carotid artery aneurysm rupture has been reported. 28 That same study reported an aortic rupture at age 57 years in the mother of an affected girl; the mother's DNA could not be tested. 28 Another study reported a history of aortic dissection in the 54-yearold mother of an affected patient, but testing for the pathogenic variant was not performed. 5 Given this history, there are reports of preemptive aortic replacement surgery in patients with pathogenic variants in FLNA and aortic aneurysms. 5 Whether medical therapy is effective in reducing the rate of dilation is unclear. The ascending aorta dilation did not resolve after transplantation, and periodic monitoring with echocardiography and/or chest MRA may be warranted.
Our case series provides evidence that loss-of-function pathogenic variants in FLNA can result in a unique form of abnormal lung development and should be considered in the differential diagnosis of congenital lung disease with marked hyperinflation. However, the phenotype was not completely penetrant in the mouse model or in the human patients. Thus, although all pathogenic variants for which parental testing was available were de novo, a review of the literature indicates that severe pulmonary complications may be observed in females who inherit the pathogenic variant in FLNA from their healthy or only mildly affected mothers, a factor complicating genetic counseling for this disorder. 12, 19 Moreover, pulmonary complications have not been described in many previously reported patients with pathogenic variants in FLNA. Perhaps skewed X-inactivation in pulmonary tissues contributes to the incomplete penetrance for the phenotype.
The present study is a retrospective chart review performed at a tertiary care referral center for pediatric lung transplantation; thus, we are unable to estimate the prevalence of pulmonary complications in patients with pathogenic variants in FLNA. In addition, because our center is a referral center for pediatric lung transplantation, the lung complications that we describe likely represent the most severe pulmonary phenotypes associated with this disorder. There are several reports of patients with pathogenic variants in FLNA who recovered from severe pulmonary complications. 12, 17 We speculate that limiting the exposure to positive-pressure ventilation, if possible, may modify the pulmonary course of these patients. Alternatively, recovery may be more likely in patients with a milder or a more localized or patchy pulmonary phenotype.
In conclusion, in a subset of patients, pathogenic variants in FLNA are associated with a severe lung growth disorder characterized by enlarged simplified alveolar air spaces and hyperinflation simulating emphysema, implying an important role of the filamin A in alveolar modeling during lung growth. This lung growth disorder may lead to respiratory failure during infancy, and these pulmonary complications may be the presenting feature of this disorder. Recognition on chest imaging is important to guide genetic testing, brain imaging, and potential referral for lung transplantation evaluation in patients with severe, progressive lung disease. Lung transplantation for children with end-stage lung disease secondary to a pathogenic variant in FLNA should be considered as therapy for the pulmonary complications of this disorder. Even after lung transplantation, close cardiology follow-up is necessary in these patients, given the risk of severe ascending aortic dilation with aortic regurgitation, which was observed in all of our patients. ■ 
